Niall J Davison (N J Davison, Niall Davison)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Topics

Hypertrophic Cardiomyopathy

Glycemic Control

Top Venues

Advances in therapy

Journal of medical economics

Genetics in medicine : official journal of the American College of Medical Genetics

This page only lists publications with an associated author ORCID identifier.

Publications

Niall J Davison, Nicole L Guthrie, Sarah Medland, Paul Lupinacci, Robert J Nordyke, Mark A Berman
Cost-Effectiveness Analysis of a Prescription Digital Therapeutic in Type 2 Diabetes. Advances in therapy 41 (2) (2024)
Michael Butzner, Csilla Kinyik-Merena, Magda Aguiar, Niall J Davison, Sanatan Shreay, Ahmad Masri
The prognostic value of peak oxygen uptake in obstructive hypertrophic cardiomyopathy: A literature review to inform economic model development. Journal of medical economics (2024)
Niall J Davison, Nicole L Guthrie, Sarah Medland, Paul Lupinacci, Robert J Nordyke, Mark A Berman
Cost-Effectiveness Analysis of a Prescription Digital Therapeutic in Type 2 Diabetes. Advances in therapy 41 (2) (2024)
Michael Butzner, Csilla Kinyik-Merena, Magda Aguiar, Niall J Davison, Sanatan Shreay, Ahmad Masri
The prognostic value of peak oxygen uptake in obstructive hypertrophic cardiomyopathy: a literature review to inform economic model development. Journal of medical economics 27 (1) (2024)
Michael Butzner, Csilla Kinyik-Merena, Magda Aguiar, Niall J Davison, Sanatan Shreay, Ahmad Masri
The prognostic value of peak oxygen uptake in obstructive hypertrophic cardiomyopathy: a literature review to inform economic model development. Journal of medical economics 27 (1) (2024)
Michael Butzner, Csilla Kinyik-Merena, Magda Aguiar, Niall J Davison, Sanatan Shreay, Ahmad Masri
The prognostic value of peak oxygen uptake in obstructive hypertrophic cardiomyopathy: A literature review to inform economic model development. Journal of medical economics (2024)
Niall J Davison, Nicole L Guthrie, Sarah Medland, Paul Lupinacci, Robert J Nordyke, Mark A Berman
Cost-Effectiveness Analysis of a Prescription Digital Therapeutic in Type 2 Diabetes. Advances in therapy 41 (2) (2024)
Niall J Davison, Nicole L Guthrie, Sarah Medland, Paul Lupinacci, Robert J Nordyke, Mark A Berman
Cost-Effectiveness Analysis of a Prescription Digital Therapeutic in Type 2 Diabetes. Advances in therapy 41 (2) (2024)
Niall J Davison, Nicole L Guthrie, Sarah Medland, Paul Lupinacci, Robert J Nordyke, Mark A Berman
Cost-Effectiveness Analysis of a Prescription Digital Therapeutic in Type 2 Diabetes. Advances in therapy 41 (2) (2024)
Niall J Davison, Nicole L Guthrie, Sarah Medland, Paul Lupinacci, Robert J Nordyke, Mark A Berman
Cost-Effectiveness Analysis of a Prescription Digital Therapeutic in Type 2 Diabetes. Advances in therapy (2024)
Rose J Hart, Darren Burns, Bram L T Ramaekers, Shijie Ren, Daniel Gladwell, William G Sullivan, Niall J Davison, Owain Saunders, Indeg Sly, Theresa Cain, Dawn Lee
R and Shiny for Cost-Effectiveness Analyses: Why and When? A Hypothetical Case Study. PharmacoEconomics 38 (7) (2021)
Caroline M Vass, Niall J Davison, Geert Vander Stichele, Katherine Payne
A Picture is Worth a Thousand Words: The Role of Survey Training Materials in Stated-Preference Studies. The patient 13 (2) (2021)
Niall J Davison, Katherine Payne, Martin Eden, Marion McAllister, Stephen A Roberts, Stuart Ingram, Graeme C M Black, Georgina Hall
Exploring the feasibility of delivering standardized genomic care using ophthalmology as an example. Genetics in medicine : official journal of the American College of Medical Genetics 19 (9) (2017)
Niall J Davison, R B Warren, K J Mason, K McElhone, B Kirby, A D Burden, C H Smith, K Payne, C E M Griffiths
Identification of factors that may influence the selection of first-line biological therapy for people with psoriasis: a prospective, multicentre cohort study. The British journal of dermatology 177 (3) (2017)